Go to Page # Page of 10
loading

Controlled-Release Formulation-Device

 Pei Kan PhD
  31st-Jul-2019
Description: Based on Device Specification, the liposome is optimized to fit in the combination system, in order to successfully deliver liposomes to a target site for localized therapy.
Views: 920
Domain: Medical
Category: Implants
Contents:
PHARMOSA Biopharm Inc.
A Start-up RD Company
Focused On

Controlled-Release Formulation-Device Combination
for Localized Therapy
Pei Kan, Ph.D.
President
http://www.pharmosa.com.tw

Dallas, Texas,
May 17, 2019

Synergy of Medical Device & Formulation Technologies
⚫ Some medications are suffering from low patient
compliance and low concentration at the target site.
⚫ Innovated medical ... See more

Recent Presentations

PFCD
15 September, 2019
ISMP Canada
13 September, 2019
...
12 September, 2019